Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-03-21

FDA Approved: XADAGO — Original Application (MDD US Operations LLC, a subsidiary of Supernus Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved XADAGO (safinamide mesylate) in an Original Application for Parkinson's disease. The applicant/manufacturer is MDD US Operations LLC, a subsidiary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xadago (safinamide)

Snippet

ORIG AP for XADAGO (SAFINAMIDE MESYLATE)